title: Successful percutaneous transcatheter aortic valve replacement in multi-organ failure due to aortic bioprosthesis regurgitation in a patient with continuous-flow LVAD.
authors.affiliation: Heart and Vascular Institute, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
authors.forename: Sameer
authors.initials: S
authors.lastname: Khan
authors.forename: Michael M
authors.initials: MM
authors.lastname: Koerner
authors.forename: Walter
authors.initials: W
authors.lastname: Pae
authors.forename: Edward R
authors.initials: ER
authors.lastname: Stephenson
authors.forename: Howard
authors.initials: H
authors.lastname: Weber
authors.forename: Christoph
authors.initials: C
authors.lastname: Brehm
authors.forename: Aly
authors.initials: A
authors.lastname: El-Banayosy
mesh_terms: D000900:Anti-Bacterial Agents; D001021:Aortic Valve; D001022:Aortic Valve Insufficiency / Q000150:complications*; D016470:Bacteremia / Q000150:complications / Q000188:drug therapy; D001705:Bioprosthesis / Q000009:adverse effects; D006328:Cardiac Catheterization / Q000379:methods*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology* / Q000628:therapy*; D011475:Prosthesis Failure / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents